Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Future Medicinal Chemistry
|
December 14, 2012
Antimalarial drug discovery: where next?
Jeremy N Burrows
The Lancet. Infectious Diseases
|
March 5, 2022
Volunteer infection studies accelerate the clinical development of novel drugs against malaria
Claudia Daubenberger, Jeremy N Burrows
Cell Host & Microbe
|
April 10, 2020
Targeting Plasmepsins-An Achilles' Heel of the Malaria Parasite
Jeremy N Burrows, Dominique Soldati-Favre
Current Topics in Medicinal Chemistry
|
March 16, 2011
The state of the art in anti-malarial drug discovery and development
Jeremy N Burrows, Kelly Chibale, Timothy N C Wells
Future Medicinal Chemistry
|
September 2, 2011
Challenges in antimalarial drug discovery
Jeremy N Burrows, Didier Leroy, Julie Lotharius, et al.
Trends in Parasitology
|
February 6, 2010
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
Timothy N C Wells, Jeremy N Burrows, J Kevin Baird
Pathogens and Global Health
|
April 21, 2015
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax
Brice Campo, Omar Vandal, David L Wesche, et al.
Molecular Biosystems
|
December 13, 2006
Fragment screening: an introduction
Andrew R Leach, Michael M Hann, Jeremy N Burrows, et al.
ACS Infectious Diseases
|
July 13, 2018
Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro
Joshua B Radke, Jeremy N Burrows, Daniel E Goldberg, et al.
Trends in Parasitology
|
August 19, 2014
Defining the biology component of the drug discovery strategy for malaria eradication
Didier Leroy, Brice Campo, Xavier C Ding, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Future Medicinal Chemistry
|
December 14, 2012
Antimalarial drug discovery: where next?
Jeremy N Burrows
The Lancet. Infectious Diseases
|
March 5, 2022
Volunteer infection studies accelerate the clinical development of novel drugs against malaria
Claudia Daubenberger, Jeremy N Burrows
Cell Host & Microbe
|
April 10, 2020
Targeting Plasmepsins-An Achilles' Heel of the Malaria Parasite
Jeremy N Burrows, Dominique Soldati-Favre
Current Topics in Medicinal Chemistry
|
March 16, 2011
The state of the art in anti-malarial drug discovery and development
Jeremy N Burrows, Kelly Chibale, Timothy N C Wells
Future Medicinal Chemistry
|
September 2, 2011
Challenges in antimalarial drug discovery
Jeremy N Burrows, Didier Leroy, Julie Lotharius, et al.
Trends in Parasitology
|
February 6, 2010
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
Timothy N C Wells, Jeremy N Burrows, J Kevin Baird
Pathogens and Global Health
|
April 21, 2015
Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax
Brice Campo, Omar Vandal, David L Wesche, et al.
Molecular Biosystems
|
December 13, 2006
Fragment screening: an introduction
Andrew R Leach, Michael M Hann, Jeremy N Burrows, et al.
ACS Infectious Diseases
|
July 13, 2018
Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro
Joshua B Radke, Jeremy N Burrows, Daniel E Goldberg, et al.
Trends in Parasitology
|
August 19, 2014
Defining the biology component of the drug discovery strategy for malaria eradication
Didier Leroy, Brice Campo, Xavier C Ding, et al.
Page
of 9